Cannabis SPAC Northern Lights Applies To List On Nasdaq,

New Post Public Reply Private Reply Replies (0) Message Board
toodles
327
Cannabis SPAC Northern Lights Applies To List On Nasdaq, Aims To Raise $100M
Nina Zdinjak 2 hrs ago

MORE AND MORE CANNABIS COMPANIES ARE DOING THIS

A cannabis-focused special purpose acquisition company, Northern Lights Acquisition Corp has plans to list on the Nasdaq Capital Market, hoping to raise $100 million with its initial public offering.

The Denver-based company filed a registration and preliminary prospectus on Tuesday with the U.S. Securities and Exchange Commission in relation to its intentioned IPO. According to the filed Form-1, Northern Lights plans to issue 10 million units with a price of $10 per unit.

ach unit would consist of one Class A share and one half of a redeemable warrant. One full warrant would enable the holder thereof to buy one Class A share at a price of $11.50 per share.

Furthermore, the underwriters would be provided with a 45-day over-allotment option to buy extra 1.5 million units.

The company noted its sponsor, 5AK LLC, has agreed to buy a total of 475,675 placement units at a price of $10 per unit, for a total purchase price of $4.76 million (or $5.28 million with a complete over-allotment option). The placement units will be sold in a private placement that is scheduled to close at the same time as the offering.

Northern Lights, meanwhile, has applied to list its common shares, units, and warrants on the Nasdaq Capital Market under the ticker symbols ‘NLIT,’ ‘NLITU’ and ‘NLITW’, respectively.

“We believe we have the opportunity to create a compelling structure that will enable one or more target companies to go public, thereby accessing significant capital for both organic growth and acquisitions of synergistic and often undercapitalized assets,” Northern Lights wrote in its filing.

The company has two co-CEOs – 1) John Darwin, who is a co-founder and president of a retail cannabis franchiser One Cannabis Group, and 2) Joshua Mann, a co-founder and managing partner of Canada-based merchant bank Luminous Capital, and was previously an interim CEO of cannabis company Indvr Brands, according to Marijuana Business Daily.

https://www.msn.com/en-us/money/companies/can...d=msedgntp

TOODLES



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Molina Healthcare: Anticipating Earnings and Market Movements

Updated Category News Views 138

Molina Healthcare's Upcoming Earnings Announcement Molina Healthcare (NYSE: MOH) is on the verge of releasing its quarterly earnings report, and investors are on high alert. The anticipated announcement will unfold on a Wednesday in the near future, and expectations are building around the company's performance. Understanding Earnings Expectations Analysts have projected...

Continue Reading
Innovative Sportswear Design Award by ANTA and Tsinghua University

Updated Category News Views 121

Introducing the 3rd Global Sportswear Design Award On an inspiring day in June, the 3rd Global Sportswear Design Award kicked off, marking a significant milestone in the world of sportswear design. This prestigious event, held at the China National Silk Museum, is a collaboration between ANTA Group and Tsinghua University. The central theme for this year's award is...

Continue Reading
Boeing's Speculation: What Lies Ahead for Its Stock?

Updated Category News Views 189

Understanding Boeing's Recent Stock Decline Boeing Company (NYSE: BA) shares experienced a noticeable drop recently. This decline followed a significant directive from the Federal Trade Commission (FTC) that requires Boeing to divest a considerable portion of its assets linked to Spirit Aerosystems Holdings, Inc. (NYSE: SPR). The market responded quickly, reflecting...

Continue Reading
Commitment to Recovery: Resilience in the Face of Disasters

Updated Category News Views 194

A Commitment to Community Resilience In recent times, our world has witnessed unprecedented weather events that remind us of the importance of community and resilient governance. Following a rare and intense rainfall that devastated many areas, community members are on the road to recovery, showcasing hope and togetherness. Devastation and Hope in Hard-Hit Regions In one...

Continue Reading
Eledon Pharmaceuticals Advances Tegoprubart for Kidney Care

Updated Category News Views 226

Exciting Advances in Kidney Transplant Rejection Prevention Recent findings from Eledon Pharmaceuticals, Inc. showcase significant results from the Phase 2 BESTOW trial, where Tegoprubart has emerged as a promising contender for preventing rejection in kidney transplant patients. Patients who continued on Tegoprubart for a year post-transplant revealed an impressive...

Continue Reading